Lakeland Industries, Inc. (NASDAQ:LAKE) Given Consensus Rating of “Hold” by Analysts

Shares of Lakeland Industries, Inc. (NASDAQ:LAKE) have been assigned a consensus rating of “Hold” from the five ratings firms that are presently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $16.00.

LAKE has been the topic of several research reports. Lake Street Capital dropped their target price on Lakeland Industries from $16.00 to $13.00 and set a “buy” rating on the stock in a research report on Friday, April 17th. Maxim Group set a $16.00 price objective on shares of Lakeland Industries in a report on Monday, April 20th. Wall Street Zen upgraded shares of Lakeland Industries from a “sell” rating to a “hold” rating in a research report on Sunday. Weiss Ratings upgraded shares of Lakeland Industries from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, June 29th. Finally, DA Davidson boosted their price objective on shares of Lakeland Industries from $14.00 to $18.00 and gave the company a “buy” rating in a research report on Thursday, June 11th.

Lakeland Industries Stock Performance

Shares of NASDAQ LAKE traded down $0.07 during midday trading on Friday, hitting $11.03. 83,161 shares of the stock traded hands, compared to its average volume of 156,373. The firm has a market capitalization of $108.87 million, a P/E ratio of -5.18 and a beta of 1.45. Lakeland Industries has a one year low of $7.15 and a one year high of $18.00. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.34 and a current ratio of 3.09. The firm has a 50-day moving average of $10.56 and a two-hundred day moving average of $9.62.

Lakeland Industries (NASDAQ:LAKE) last issued its quarterly earnings data on Tuesday, June 9th. The medical instruments supplier reported $0.04 EPS for the quarter, topping the consensus estimate of ($0.14) by $0.18. The company had revenue of $47.42 million during the quarter, compared to analyst estimates of $47.36 million. Lakeland Industries had a negative return on equity of 6.64% and a negative net margin of 10.87%. On average, equities analysts forecast that Lakeland Industries will post -0.28 EPS for the current fiscal year.

Institutional Investors Weigh In On Lakeland Industries

Several hedge funds and other institutional investors have recently added to or reduced their stakes in LAKE. Pacific Ridge Capital Partners LLC lifted its stake in shares of Lakeland Industries by 62.3% during the 4th quarter. Pacific Ridge Capital Partners LLC now owns 772,015 shares of the medical instruments supplier’s stock valued at $6,825,000 after buying an additional 296,222 shares in the last quarter. Peapod Lane Capital LLC purchased a new stake in Lakeland Industries in the 4th quarter worth $604,000. Equitable Trust Co. raised its holdings in Lakeland Industries by 10.4% during the fourth quarter. Equitable Trust Co. now owns 29,990 shares of the medical instruments supplier’s stock valued at $265,000 after acquiring an additional 2,820 shares during the period. Salvus Wealth Management LLC purchased a new position in shares of Lakeland Industries in the fourth quarter valued at about $122,000. Finally, Crawford Investment Counsel Inc. lifted its position in shares of Lakeland Industries by 13.9% in the third quarter. Crawford Investment Counsel Inc. now owns 208,398 shares of the medical instruments supplier’s stock valued at $3,084,000 after acquiring an additional 25,429 shares in the last quarter. 71.69% of the stock is owned by hedge funds and other institutional investors.

About Lakeland Industries

Lakeland Industries, Inc (NASDAQ:LAKE) is a global provider of high-performance protective apparel and accessories designed to safeguard workers in industrial, healthcare, laboratory, and emergency response environments. The company’s expertise lies in producing garments that shield against chemical, biological, radiological, and thermal risks, supporting safety protocols in sectors such as oil and gas, petrochemicals, pharmaceuticals, and first responders.

The product portfolio encompasses both single-use and reusable solutions, including chemical protective coveralls, flame-resistant garments, arc flash clothing, medical isolation gowns, and cleanroom suits.